4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-17-012934
Chief Development Officer bought 11,111 shares at $9.99 ($110,999)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TURKEL CATHERINE C. Chief Development Officer | 2017-05-10 | Purchase | +11,111 | $9.99 | $110,999 | 24,519 | D |
| Open-market purchases · 11,111 sh · avg $9.99 · $110,999 | |||||||
Loading xslF345X03/doc4.xml…